Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Vascular endothelial growth factor can signal through platelet-derived growth factor receptors
Stephen G. Ball1,2,
C. Adrian Shuttleworth2, , and
Cay M. Kielty1,2
1 UK Centre for Tissue Engineering and 2 Wellcome Trust Centre for Cell-Matrix Research, Faculty of Life Sciences, The University of Manchester, Manchester M13 9PT, England, UK
Correspondence to C. Adrian Shuttleworth: adrian.shuttleworth{at}manchester.ac.uk; or Cay M. Kielty: cay.kielty{at}manchester.ac.uk
Abstract:
Vascular endothelial growth factor (VEGF-A) is a crucial stimulatorof vascular cell migration and proliferation. Using bone marrowderivedhuman adult mesenchymal stem cells (MSCs) that did not expressVEGF receptors, we provide evidence that VEGF-A can stimulateplatelet-derived growth factor receptors (PDGFRs), thereby regulatingMSC migration and proliferation. VEGF-A binds to both PDGFRand PDGFRß and induces tyrosine phosphorylation that,when inhibited, results in attenuation of VEGF-AinducedMSC migration and proliferation. This mechanism was also shownto mediate human dermal fibroblast (HDF) migration. VEGF-A/PDGFRsignaling has the potential to regulate vascular cell recruitmentand proliferation during tissue regeneration and disease.
Abbreviations used in this paper: DTSSP, 3, 3'-Dithiobis[sulfosuccinimidylpropionate]; HDF, human dermal fibroblast; HUVEC, human umbilicalvein endothelial cell; MSC, mesenchymal stem cell; NP, neuropilin;PDGFR, PDGF receptor; PVF, PDGF/VEGF-like factor; RTK, receptortyrosine kinase; VEGF, vascular endothelial growth factor; VEGFR,VEGF receptor.
The editors suggest the following Related Resources on Science sites:
In Science Signaling
EDITORS' CHOICE
Nancy R. Gough (15 May 2007) Sci. STKE2007 (386), tw167.
[DOI: 10.1126/stke.3862007tw167] |Abstract »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
S-nitrosoglutathione reductase (GSNOR) enhances vasculogenesis by mesenchymal stem cells.
S. A. Gomes, E. B. Rangel, C. Premer, R. A. Dulce, Y. Cao, V. Florea, W. Balkan, C. O. Rodrigues, A. V. Schally, and J. M. Hare (2013)
PNAS
110, 2834-2839
|Abstract »|Full Text »|PDF »
Chronic hypoxia and VEGF differentially modulate abundance and organization of myosin heavy chain isoforms in fetal and adult ovine arteries.
M. C. Hubbell, A. J. Semotiuk, R. B. Thorpe, O. O. Adeoye, S. M. Butler, J. M. Williams, O. Khorram, and W. J. Pearce (2012)
Am J Physiol Cell Physiol
303, C1090-C1103
|Abstract »|Full Text »|PDF »
Angiopoietins/TIE2 System and VEGF Are Involved in Ovarian Function in a DHEA Rat Model of Polycystic Ovary Syndrome.
D. Abramovich, G. Irusta, D. Bas, N. I. Cataldi, F. Parborell, and M. Tesone (2012)
Endocrinology
153, 3446-3456
|Abstract »|Full Text »|PDF »
Vascular Endothelial Growth Factor A Competitively Inhibits Platelet-Derived Growth Factor (PDGF)-Dependent Activation of PDGF Receptor and Subsequent Signaling Events and Cellular Responses.
The Antifungal Drug Itraconazole Inhibits Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Glycosylation, Trafficking, and Signaling in Endothelial Cells.
B. A. Nacev, P. Grassi, A. Dell, S. M. Haslam, and J. O. Liu (2011)
J. Biol. Chem.
286, 44045-44056
|Abstract »|Full Text »|PDF »
Contributions of VEGF to age-dependent transmural gradients in contractile protein expression in ovine carotid arteries.
S. M. Butler, J. M. Abrassart, M. C. Hubbell, O. Adeoye, A. Semotiuk, J. M. Williams, E. Mata-Greenwood, O. Khorram, and W. J. Pearce (2011)
Am J Physiol Cell Physiol
301, C653-C666
|Abstract »|Full Text »|PDF »
Mesenchymal stem cell migration is regulated by fibronectin through {alpha}5{beta}1-integrin-mediated activation of PDGFR-{beta} and potentiation of growth factor signals.
J. Veevers-Lowe, S. G. Ball, A. Shuttleworth, and C. M. Kielty (2011)
J. Cell Sci.
124, 1288-1300
|Abstract »|Full Text »|PDF »
Platelet-derived growth factor (PDGF)-PDGF receptor interaction activates bone marrow-derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications for an angiogenic switch.
W. Ding, T. R. Knox, R. C. Tschumper, W. Wu, S. M. Schwager, J. C. Boysen, D. F. Jelinek, and N. E. Kay (2010)
Blood
116, 2984-2993
|Abstract »|Full Text »|PDF »
Targeting the {alpha} Receptor for Platelet-Derived Growth Factor as a Primary or Combination Therapy in a Preclinical Model of Prostate Cancer Skeletal Metastasis.
M. R. Russell, Q. Liu, and A. Fatatis (2010)
Clin. Cancer Res.
16, 5002-5010
|Abstract »|Full Text »|PDF »
Structures of a platelet-derived growth factor/propeptide complex and a platelet-derived growth factor/receptor complex.
A. Hye-Ryong Shim, H. Liu, P. J. Focia, X. Chen, P. C. Lin, and X. He (2010)
PNAS
107, 11307-11312
|Abstract »|Full Text »|PDF »
Sox2 Transduction Enhances Cardiovascular Repair Capacity of Blood-Derived Mesoangioblasts.
M. Koyanagi, M. Iwasaki, S. Rupp, F. S. Tedesco, C. H. Yoon, J. N. Boeckel, J. Trauth, C. Schutz, K. Ohtani, R. Goetz, et al. (2010)
Circ. Res.
106, 1290-1302
|Abstract »|Full Text »|PDF »
Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression.
A. K. Ghosh, C. R. Secreto, T. R. Knox, W. Ding, D. Mukhopadhyay, and N. E. Kay (2010)
Blood
115, 1755-1764
|Abstract »|Full Text »|PDF »
Stem cell-mediated neovascularization in heart repair.
C. Nesselmann, W. Li, N. Ma, and G. Steinhoff (2010)
Therapeutic Advances in Cardiovascular Disease
4, 27-42
|Abstract »|PDF »
Compartmentalizing VEGF-Induced ERK2/1 Signaling in Placental Artery Endothelial Cell Caveolae: A Paradoxical Role of Caveolin-1 in Placental Angiogenesis in Vitro.
W.-x. Liao, L. Feng, H. Zhang, J. Zheng, T. R. Moore, and D.-b. Chen (2009)
Mol. Endocrinol.
23, 1428-1444
|Abstract »|Full Text »|PDF »
Regulation of Platelet-derived Growth Factor Receptor Function by Integrin-associated Cell Surface Transglutaminase.
E. A. Zemskov, E. Loukinova, I. Mikhailenko, R. A. Coleman, D. K. Strickland, and A. M. Belkin (2009)
J. Biol. Chem.
284, 16693-16703
|Abstract »|Full Text »|PDF »
Gene Expression Profile and Angiogenic Markers Correlate with Response to Neoadjuvant Bevacizumab Followed by Bevacizumab plus Chemotherapy in Breast Cancer.
S. X. Yang, S. M. Steinberg, D. Nguyen, T. D. Wu, Z. Modrusan, and S. M. Swain (2008)
Clin. Cancer Res.
14, 5893-5899
|Abstract »|Full Text »|PDF »
Role of platelet-derived growth factors in physiology and medicine.
Cyclic strain induces mouse embryonic stem cell differentiation into vascular smooth muscle cells by activating PDGF receptor {beta}.
N. Shimizu, K. Yamamoto, S. Obi, S. Kumagaya, T. Masumura, Y. Shimano, K. Naruse, J. K. Yamashita, T. Igarashi, and J. Ando (2008)
J Appl Physiol
104, 766-772
|Abstract »|Full Text »|PDF »
Vascular endothelial growth factor can signal through platelet-derived growth factor receptors.
S. G. Ball, C. A. Shuttleworth, and C. M. Kielty (2007)
J. Exp. Med.
204, i15
|Full Text »